GSK Close to Deal with Nanjing MeiRui Pharma Of China
This article was originally published in PharmAsia News
Executive Summary
China's Nanjing MeiRui Pharma is on the threshold of being bought by U.K. drug-maker GlaxoSmithKline, according to sources, one of whom said an announcement could be made by the end of the year